Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Donoghoe

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Methods|May 29, 2023
Learning consistent subcellular landmarks to quantify changes in multiplexed protein mapsHannah Spitzer, Scott Berry, Mark Donoghoe, et al.
Plos One|February 23, 2024
The lived experience of people affected by cancer: A global cross-sectional survey protocolJulie Cayrol, Claire E Wakefield, André Ilbawi, et al.
The Journal of Pediatrics|October 14, 2018
Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen TrialsBenjamin J Stenson, Mark Donoghoe, Peter Brocklehurst, et al.
Diabetes Research and Clinical Practice|August 25, 2011
Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD studyDavid Sullivan, Peta Forder, John Simes, et al.
BMC Public Health|December 22, 2018
Epidemic surveillance in a low resource setting: lessons from an evaluation of the Solomon Islands syndromic surveillance system, 2017Adam T Craig, Cynthia A Joshua, Alison R Sio, et al.
JCO Oncology Practice|February 20, 2025
Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of LifeChristina Signorelli, Jordana McLoone, Claire Wakefield, et al.
Journal of Gynecologic Oncology|October 30, 2013
Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG studyPrunella Blinman, Corona Gainford, Mark Donoghoe, et al.
Cardiovascular Diabetology|November 23, 2011
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialRussell Scott, Mark Donoghoe, Gerald F Watts, et al.
Gynecologic Oncology|May 18, 2011
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trialFlorence Joly, Isabelle Ray-Coquard, Michel Fabbro, et al.
The Journal of Pediatrics|February 25, 2014
Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomesBrian A Darlow, Simone L Marschner, Mark Donoghoe, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Methods|May 29, 2023
Learning consistent subcellular landmarks to quantify changes in multiplexed protein mapsHannah Spitzer, Scott Berry, Mark Donoghoe, et al.
Plos One|February 23, 2024
The lived experience of people affected by cancer: A global cross-sectional survey protocolJulie Cayrol, Claire E Wakefield, André Ilbawi, et al.
The Journal of Pediatrics|October 14, 2018
Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen TrialsBenjamin J Stenson, Mark Donoghoe, Peter Brocklehurst, et al.
Diabetes Research and Clinical Practice|August 25, 2011
Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD studyDavid Sullivan, Peta Forder, John Simes, et al.
BMC Public Health|December 22, 2018
Epidemic surveillance in a low resource setting: lessons from an evaluation of the Solomon Islands syndromic surveillance system, 2017Adam T Craig, Cynthia A Joshua, Alison R Sio, et al.
JCO Oncology Practice|February 20, 2025
Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of LifeChristina Signorelli, Jordana McLoone, Claire Wakefield, et al.
Journal of Gynecologic Oncology|October 30, 2013
Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG studyPrunella Blinman, Corona Gainford, Mark Donoghoe, et al.
Cardiovascular Diabetology|November 23, 2011
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialRussell Scott, Mark Donoghoe, Gerald F Watts, et al.
Gynecologic Oncology|May 18, 2011
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trialFlorence Joly, Isabelle Ray-Coquard, Michel Fabbro, et al.
The Journal of Pediatrics|February 25, 2014
Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomesBrian A Darlow, Simone L Marschner, Mark Donoghoe, et al.
Pageof 2